Prevention of congenital toxoplasmosis in Szeged, Hungary | Zendy

Z Szénási | Zendy; Zsófia Ozsvár | Zendy; Erzsébet Nagy | Zendy; M Jeszenszky | Zendy; János Szabó | Zendy; J Gellén | Zendy; M Végh | Zendy; Chris Verhofstede | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevention of congenital toxoplasmosis in Szeged, Hungary

Author(s) -

Z Szénási,

Zsófia Ozsvár,

Erzsébet Nagy,

M Jeszenszky,

János Szabó,

J Gellén,

M Végh,

Chris Verhofstede

Publication year - 1997

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/26.2.428

Subject(s) - spiramycin , toxoplasmosis , seroconversion , serology , offspring , medicine , pregnancy , complement fixation test , toxoplasma gondii , antibody , immunology , gestation , obstetrics , pediatrics , biology , antibiotics , genetics , erythromycin , microbiology and biotechnology

Toxoplasma gondii infection of the fetus can only be discovered or prevented by the appropriate serological screening and subsequent treatment of the mother and her offspring. In Hungary, there is no obligatory toxoplasma screening for pregnant women and both the reporting and follow-up of congenital toxoplasmosis cases is limited. In 1987 we started a systematic study in the Szeged region of Hungary, in which all pregnant women were screened and appropriate treatment given to all mothers and their offspring where congenital toxoplasmosis was suspected.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research